Cargando…

Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065

The natural antibiotics CC‑1065 and the duocarmycins are highly cytotoxic compounds which however are not suitable for cancer therapy due to their general toxicity. We have developed glycosidic prodrugs of seco-analogues of these antibiotics for a selective cancer therapy using conjugates of glycohy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tietze, Lutz F., Krewer, Birgit, von Hof, J. Marian, Frauendorf, Holm, Schuberth, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202783/
https://www.ncbi.nlm.nih.gov/pubmed/22069536
http://dx.doi.org/10.3390/toxins1020134
_version_ 1782215031833755648
author Tietze, Lutz F.
Krewer, Birgit
von Hof, J. Marian
Frauendorf, Holm
Schuberth, Ingrid
author_facet Tietze, Lutz F.
Krewer, Birgit
von Hof, J. Marian
Frauendorf, Holm
Schuberth, Ingrid
author_sort Tietze, Lutz F.
collection PubMed
description The natural antibiotics CC‑1065 and the duocarmycins are highly cytotoxic compounds which however are not suitable for cancer therapy due to their general toxicity. We have developed glycosidic prodrugs of seco-analogues of these antibiotics for a selective cancer therapy using conjugates of glycohydrolases and tumour-selective monoclonal antibodies for the liberation of the drugs from the prodrugs predominantly at the tumour site. For the determination of structure activity relationships of the different seco-drugs, experiments addressing their interaction with synthetic DNA were performed. Using electro­spray mass spectrometry and high performance liquid chromatography, the experiments revealed a correlation of the stability of these drugs with their cytotoxicity in cell culture investigations. Furthermore, it was shown that the drugs bind to AT-rich regions of double-stranded DNA and the more cytotoxic drugs induce DNA fragmentation at room temperature in several of the selected DNA double-strands. Finally, an explanation for the very high cytotoxicity of CC-1065, the duocarmycins and analogous drugs is given.
format Online
Article
Text
id pubmed-3202783
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-32027832011-11-08 Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065 Tietze, Lutz F. Krewer, Birgit von Hof, J. Marian Frauendorf, Holm Schuberth, Ingrid Toxins (Basel) Article The natural antibiotics CC‑1065 and the duocarmycins are highly cytotoxic compounds which however are not suitable for cancer therapy due to their general toxicity. We have developed glycosidic prodrugs of seco-analogues of these antibiotics for a selective cancer therapy using conjugates of glycohydrolases and tumour-selective monoclonal antibodies for the liberation of the drugs from the prodrugs predominantly at the tumour site. For the determination of structure activity relationships of the different seco-drugs, experiments addressing their interaction with synthetic DNA were performed. Using electro­spray mass spectrometry and high performance liquid chromatography, the experiments revealed a correlation of the stability of these drugs with their cytotoxicity in cell culture investigations. Furthermore, it was shown that the drugs bind to AT-rich regions of double-stranded DNA and the more cytotoxic drugs induce DNA fragmentation at room temperature in several of the selected DNA double-strands. Finally, an explanation for the very high cytotoxicity of CC-1065, the duocarmycins and analogous drugs is given. Molecular Diversity Preservation International 2009-12-02 /pmc/articles/PMC3202783/ /pubmed/22069536 http://dx.doi.org/10.3390/toxins1020134 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Tietze, Lutz F.
Krewer, Birgit
von Hof, J. Marian
Frauendorf, Holm
Schuberth, Ingrid
Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title_full Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title_fullStr Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title_full_unstemmed Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title_short Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065
title_sort determination of the biological activity and structure activity relationships of drugs based on the highly cytotoxic duocarmycins and cc-1065
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202783/
https://www.ncbi.nlm.nih.gov/pubmed/22069536
http://dx.doi.org/10.3390/toxins1020134
work_keys_str_mv AT tietzelutzf determinationofthebiologicalactivityandstructureactivityrelationshipsofdrugsbasedonthehighlycytotoxicduocarmycinsandcc1065
AT krewerbirgit determinationofthebiologicalactivityandstructureactivityrelationshipsofdrugsbasedonthehighlycytotoxicduocarmycinsandcc1065
AT vonhofjmarian determinationofthebiologicalactivityandstructureactivityrelationshipsofdrugsbasedonthehighlycytotoxicduocarmycinsandcc1065
AT frauendorfholm determinationofthebiologicalactivityandstructureactivityrelationshipsofdrugsbasedonthehighlycytotoxicduocarmycinsandcc1065
AT schuberthingrid determinationofthebiologicalactivityandstructureactivityrelationshipsofdrugsbasedonthehighlycytotoxicduocarmycinsandcc1065